Skip to main content

Table 2 Treatment regimen at baseline and follow-up, level of compliance and inhaler technique

From: Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care

N = 330

Baseline

4 months

8 months

12 months

No continuing tx (on demand)

23.3%

9.8%

12.6%

9.9%

Inhaled steroids mono-tx

8.9%

8.3%

7.7%

7.1%

Formoterol/budesonide

20.8

26.5%

26.2%

26.2%

Salmeterol/fluticasone

46.9%

52.1%

53.5%

56.5%

Montelukast

32.4%

40.1%

47.9%

50%

Equivalent dose of inhaled steroids

1185.5

(780.1)

1276.6

(922.3)

1249.3

(851.9)

1221.5

(822.9)

Compliance inhaled medication

 Good

74.1%

77.1%

85.8%

86.3%

 Fair

5.6%

7.4%

5.1%

6.2%

 Poor

20.3%

15.5%

9.2%

7.5%

Compliance oral medication

 Good

72%

81.3%

86.7%

91.1%

 Fair

4.8%

2.7%

2.8%

2.6%

 Poor

23.2%

15.9%

10.5%

6.3%

Inhaler technique

 Correct

74.1%

88.7%

92%

96.1%